The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

Although Δ(9)-tetrahydrocannabinol (THC) and other mixed CB(1)/CB(2) receptor agonists are well established to elicit antinociceptive effects, their psychomimetic actions and potential for abuse have dampened enthusiasm for their therapeutic development. Conversely, CB(2) receptor-selective agonists...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kinsey, Steven G., Mahadevan, Anu, Zhao, Bingjun, Sun, Hang, Naidu, Pattipati S., Razdan, Raj K., Selley, Dana E., Damaj, M. Imad, Lichtman, Aron H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021987/
https://ncbi.nlm.nih.gov/pubmed/20849866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2010.09.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados